FDA proposes guidance for generic drug development
from Pharmacy Times
The FDA is seeking comments on 28 new and 15 revised recommendations providing product-specific guidance on the design of bioequivalence studies to support Abbreviated New Drug Applications.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063